RxDoctor Payments Data

Russell Cohen, MD

Adult Reconstructive Orthopaedic Surgery · Tucson, AZNPI 1700887460

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $808,075 of the $969,733 with a category attached, or 83.3%. Stryker accounts for 100.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $315,161 and has fallen 81.1% since, to $59,482 in 2025. Among adult reconstructive orthopaedic surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$969,733in general payments, 2019–2025

Across 667 payments — averaging $1453.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$970K
  • Nevro Corp.$29
  • Pfizer$29
  • Smith+Nephew$28
  • Boston Scientific$15
$30,779in research payments, 2019–2025

Across 18 payments — averaging $1709.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$31K

What the payments were for

  • Consulting fees$808,07583%
  • Travel & lodging$146,94115%
  • Food & beverage$14,7182%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker663$969,632
Nevro Corp.1$29
Pfizer1$29
Smith+Nephew1$28
Boston Scientific1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$969,733 in reported general payments places this provider in the 95th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.

See all adult reconstructive orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$482,865
Medicare patients
648
Services billed
3,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib37$785
Meloxicam290$747
Gabapentin11$54

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →